Tag Archives: Medicaid

ACA Supreme Court Deliberations and Any Impact on Biosimilars?

If the court strikes down the ACA entirely, biosimilars on the U.S. market or in the FDA approval pipeline would have to either be grandfathered in or face a regulatory wind-down

AscellaHealth and BioMatrix Specialty Pharmacy Strengthen Relationship

BioMatrix offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions

Immunomedics Chooses Biologics as Sole Specialty Pharmacy Distributor

Trodelvy is the first anti-Trop-2 ADC recently approved by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease

Key Trends in Healthcare for 2020 and Beyond

Transparency has been elevated as consumerism marches forward in the face of steadily increasing healthcare costs

Rebates? Strategy from The Football Playbook – The End Around

I failed to discern the implication of the actions proposed by the HHS-FDA Safe Importation Action Plan and the magnitude of its impact to rebates.